265 related articles for article (PubMed ID: 2993441)
1. Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome.
Preble OT; Rook AH; Steis R; Silverman RH; Krause D; Quinnan GV; Masur H; Jacob J; Longo D; Gelmann EP
J Infect Dis; 1985 Sep; 152(3):457-65. PubMed ID: 2993441
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of interferon-induced 2'-5' oligoadenylate synthetase in generalized persistent lymphadenopathy and the acquired immunodeficiency syndrome.
Read SE; Williams BR; Coates RA; Evans WK; Fanning MM; Garvey MB; Shepherd FA
J Infect Dis; 1985 Sep; 152(3):466-72. PubMed ID: 2411826
[TBL] [Abstract][Full Text] [Related]
3. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
[TBL] [Abstract][Full Text] [Related]
4. Hormonal and immunological regulation of 2', 5'-oligoadenylate synthetase activity in human peripheral blood mononuclear cells.
Miele ME; Vesell ES; Ehmann WC; Lipton A; Harvey H; Kan NC
Clin Immunol Immunopathol; 1992 Nov; 65(2):183-92. PubMed ID: 1356675
[TBL] [Abstract][Full Text] [Related]
5. Viral infections and cell-mediated immunity in immunodeficient homosexual men with Kaposi's sarcoma treated with human lymphoblastoid interferon.
Frederick WR; Epstein JS; Gelmann EP; Rook AH; Armstrong GR; Djeu JY; Jackson L; Manischewitz JF; Enterline J; Jacob J
J Infect Dis; 1985 Jul; 152(1):162-70. PubMed ID: 2989380
[TBL] [Abstract][Full Text] [Related]
6. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase.
Rosenblum MG; Maxwell BL; Talpaz M; Kelleher PJ; McCredie KB; Gutterman JU
Cancer Res; 1986 Sep; 46(9):4848-52. PubMed ID: 2942242
[TBL] [Abstract][Full Text] [Related]
7. Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha.
Merritt JA; Borden EC; Ball LA
J Interferon Res; 1985; 5(1):191-8. PubMed ID: 3989336
[TBL] [Abstract][Full Text] [Related]
8. Interferon and 2-5A synthetase in patients with immune diseases.
Preble OT; Yeh TJ; Silverman RH; Klippel JH; Straus SE; Gelmann EP
Prog Clin Biol Res; 1985; 202():415-22. PubMed ID: 2421319
[No Abstract] [Full Text] [Related]
9. Interleukin-6 concentrations in the serum of patients with AIDS-associated Kaposi's sarcoma during treatment with interferon-alpha.
de Wit R; Raasveld MH; ten Berge RJ; van der Wouw PA; Bakker PJ; Veenhof CH
J Intern Med; 1991 Jun; 229(6):539-42. PubMed ID: 2045763
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy and alpha-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndrome.
Shepherd FA; Evans WK; Garvey B; Read SE; Klein M; Fanning MM; Coates R
CMAJ; 1988 Oct; 139(7):635-9. PubMed ID: 2458177
[TBL] [Abstract][Full Text] [Related]
11. 2-5A synthetase activity in patients with metastatic carcinoma and its response to interferon treatment.
Merritt JA; Meltzer DM; Ball LA; Borden EC
Prog Clin Biol Res; 1985; 202():423-30. PubMed ID: 3832076
[TBL] [Abstract][Full Text] [Related]
12. (2'-5') Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections.
Schattner A; Merlin G; Bregman V; Hahn T; Levin S; Revel M; Wallach D
Clin Exp Immunol; 1984 Aug; 57(2):265-70. PubMed ID: 6467673
[TBL] [Abstract][Full Text] [Related]
13. Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma.
Krown SE; Real FX; Cunningham-Rundles S; Myskowski PL; Koziner B; Fein S; Mittelman A; Oettgen HF; Safai B
N Engl J Med; 1983 May; 308(18):1071-6. PubMed ID: 6835320
[No Abstract] [Full Text] [Related]
14. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B.
Furuta M; Akashi K; Nakamura Y; Matsumoto K; Yamaguchi H; Takamatsu S; Shimizu T
J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079
[TBL] [Abstract][Full Text] [Related]
15. Malignancies in the AIDS patient: natural history, treatment strategies, and preliminary results.
Longo DL; Steis RG; Lane HC; Lotze MT; Rosenberg SA; Preble O; Masur H; Rook AH; Fauci AS; Jacob J
Ann N Y Acad Sci; 1984; 437():421-30. PubMed ID: 6598311
[TBL] [Abstract][Full Text] [Related]
16. Induction of 2',5'-oligoadenylate synthetase by retinoic acid in two transformed human cell lines.
Bourgeade MF; Besançon F
Cancer Res; 1984 Nov; 44(11):5355-60. PubMed ID: 6435868
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acquired immunodeficiency syndrome--related Kaposi's sarcoma with lymphoblastoid interferon.
Rios A; Mansell PW; Newell GR; Reuben JM; Hersh EM; Gutterman JU
J Clin Oncol; 1985 Apr; 3(4):506-12. PubMed ID: 3872349
[TBL] [Abstract][Full Text] [Related]
18. 2',5'-Oligoadenylate synthetase activity as a responsive marker during interferon therapy for chronic hepatitis C.
Giannelli G; Antonelli G; Fera G; Dianzani F; Schiraldi O
J Interferon Res; 1993 Feb; 13(1):57-60. PubMed ID: 8454912
[TBL] [Abstract][Full Text] [Related]
19. 2',5'-Oligoadenylate synthetase levels in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b do not correlate with clinical response.
Millar BC; Bell JB
Br J Cancer; 1995 Dec; 72(6):1525-30. PubMed ID: 8519671
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of 5 patients affected by Kaposi's sarcoma and AIDS with recombinant interferon alfa-2A (roferon-A)].
Lopez Bran E; Aguilar R; Marron JA; Figueredo MA; Garcia Ruiz JM
Med Cutan Ibero Lat Am; 1989; 17(4):269-73. PubMed ID: 2693866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
